Further analysis of RNAseq data from The Cancer Genome Atlas (TCGA) corroborated our findings, indicating a correlation between high gene expression levels, particularly CXCL10, with greater tumor mutational burden and improved survival rates. This evidence concerns the gene CXCL10 and neoplasm.